Amundi’s West Pharmaceutical WST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$111M Buy
502,831
+228,696
+83% +$50.6M 0.04% 392
2025
Q1
$60.3M Sell
274,135
-57,646
-17% -$12.7M 0.02% 510
2024
Q4
$112M Buy
331,781
+93,692
+39% +$31.6M 0.04% 403
2024
Q3
$68.2M Sell
238,089
-126,351
-35% -$36.2M 0.03% 484
2024
Q2
$117M Buy
364,440
+36,189
+11% +$11.6M 0.04% 343
2024
Q1
$124M Sell
328,251
-50,764
-13% -$19.2M 0.05% 336
2023
Q4
$132M Buy
379,015
+214
+0.1% +$74.8K 0.06% 328
2023
Q3
$146M Buy
378,801
+825
+0.2% +$318K 0.07% 284
2023
Q2
$143M Buy
377,976
+28,026
+8% +$10.6M 0.07% 295
2023
Q1
$121M Buy
349,950
+51,518
+17% +$17.9M 0.07% 309
2022
Q4
$75M Sell
298,432
-116,954
-28% -$29.4M 0.04% 411
2022
Q3
$108M Buy
415,386
+138,698
+50% +$36M 0.06% 315
2022
Q2
$81.5M Buy
276,688
+9,315
+3% +$2.74M 0.07% 302
2022
Q1
$112M Sell
267,373
-5,940
-2% -$2.5M 0.08% 275
2021
Q4
$104M Sell
273,313
-31,876
-10% -$12.1M 0.07% 313
2021
Q3
$130M Buy
305,189
+4,198
+1% +$1.78M 0.09% 240
2021
Q2
$108M Buy
+300,991
New +$108M 0.08% 274